JP Morgan Cazenove Reiterates M&G (MGPUF) Overweight Recommendation

JP Morgan Cazenove reiterated an "Overweight" recommendation for M&G (OTCPK:MGPUF) on November 7, 2025, setting an average one-year price target of $3.68/share, which implies a significant 44.48% upside from its latest closing price of $2.55. This positive outlook is underpinned by robust financial projections, including an anticipated 246.30% increase in annual revenue to 21,959MM and a projected non-GAAP EPS of $0.22. Institutional investor sentiment also remains strong, with total shares owned by institutions increasing by 5.53% and the average portfolio weight dedicated to MGPUF rising by 20.86% over the last quarter, signaling continued confidence from major funds.

Analysis

JP Morgan Cazenove reiterated an "Overweight" recommendation for M&G (OTCPK:MGPUF) on November 7, 2025, signaling a strong positive outlook. The average one-year price target is set at $3.68 per share, representing a significant 44.48% upside from the latest reported closing price of $2.55. This target range spans from a low of $2.89 to a high of $4.78, indicating a broad consensus for substantial appreciation.

The bullish analyst stance is underpinned by robust financial projections for M&G. The company is projected to achieve annual revenue of 21,959MM, marking an extraordinary increase of 246.30%. Concurrently, the projected annual non-GAAP EPS stands at $0.22, further supporting the positive fundamental outlook.

Institutional investor sentiment remains highly positive, with 216 funds reporting positions, unchanged from the prior quarter. Total shares owned by institutions increased by 5.53% to 235,439K shares, while the average portfolio weight dedicated to MGPUF rose by 20.86%. Notable increases in holdings include Vanguard Total International Stock Index Fund (+7.47% shares) and Vanguard Developed Markets Index Fund Admiral Shares (+8.38% shares), reflecting growing conviction among major asset managers.

Key Decisions for Investors

• Consider M&G (MGPUF) for potential capital appreciation given the "Overweight" rating and 44.48% price target upside.
• Monitor the company's progress against its ambitious revenue growth projection of 246.30% and projected non-GAAP EPS of $0.22 as key performance indicators.
• Note the strong and increasing institutional ownership, which suggests growing confidence from major funds and could provide support for the stock.